JPS59157021A - 動脈硬化症予防治療剤 - Google Patents

動脈硬化症予防治療剤

Info

Publication number
JPS59157021A
JPS59157021A JP58031515A JP3151583A JPS59157021A JP S59157021 A JPS59157021 A JP S59157021A JP 58031515 A JP58031515 A JP 58031515A JP 3151583 A JP3151583 A JP 3151583A JP S59157021 A JPS59157021 A JP S59157021A
Authority
JP
Japan
Prior art keywords
diltiazem
arteriosclerosis
preventive
agent
remedy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58031515A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6358809B2 (enrdf_load_stackoverflow
Inventor
Azusa Okaniwa
岡庭　梓
Hitoshi Iwasaki
仁 岩崎
Kazuyuki Kitamura
和之 北村
Takashi Morita
守田　隆志
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority to JP58031515A priority Critical patent/JPS59157021A/ja
Priority to NL8400548A priority patent/NL8400548A/nl
Priority to SE8400971A priority patent/SE8400971L/
Priority to FR8402895A priority patent/FR2541577B1/fr
Priority to DE19843406837 priority patent/DE3406837A1/de
Priority to BE0/212448A priority patent/BE899000A/fr
Priority to CH925/84A priority patent/CH658389A5/de
Priority to IT8467183A priority patent/IT1178863B/it
Priority to DK103084A priority patent/DK163712C/da
Priority to GB08405060A priority patent/GB2135192B/en
Publication of JPS59157021A publication Critical patent/JPS59157021A/ja
Publication of JPS6358809B2 publication Critical patent/JPS6358809B2/ja
Priority to SG211/89A priority patent/SG21189G/en
Priority to HK453/89A priority patent/HK45389A/xx
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
JP58031515A 1983-02-25 1983-02-25 動脈硬化症予防治療剤 Granted JPS59157021A (ja)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP58031515A JPS59157021A (ja) 1983-02-25 1983-02-25 動脈硬化症予防治療剤
NL8400548A NL8400548A (nl) 1983-02-25 1984-02-21 Farmaceutische preparaat voor de profylaxe en behandeling van arteriosclerose.
SE8400971A SE8400971L (sv) 1983-02-25 1984-02-22 Profylaktiskt och lekande medel for arterioskleros
IT8467183A IT1178863B (it) 1983-02-25 1984-02-24 Composizione farmaceutica per la profilassi ed il trattemento della arteriosclerosi
DE19843406837 DE3406837A1 (de) 1983-02-25 1984-02-24 Arteriosklerose-arzneimittel und -prophylaktikum
BE0/212448A BE899000A (fr) 1983-02-25 1984-02-24 Compositions a base de diltiazem pour la prophylaxie et le traitement des arterioscleroses
CH925/84A CH658389A5 (de) 1983-02-25 1984-02-24 Pharmazeutisches mittel fuer prophylaxe und behandlung von arteriosklerose.
FR8402895A FR2541577B1 (fr) 1983-02-25 1984-02-24 Nouveau medicament pour la prophylaxie et la guerison de l'arteriosclerose
DK103084A DK163712C (da) 1983-02-25 1984-02-24 Anvendelse af diltiazem eller et farmaceutisk acceptabelt syreadditionssalt deraf
GB08405060A GB2135192B (en) 1983-02-25 1984-02-27 Diltiazem for the treatment of arteriosclerosis
SG211/89A SG21189G (en) 1983-02-25 1989-04-07 Prophylactic and curing agent for arteriosclerosis
HK453/89A HK45389A (en) 1983-02-25 1989-06-07 Prophylactic and curing agent for arteriosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58031515A JPS59157021A (ja) 1983-02-25 1983-02-25 動脈硬化症予防治療剤

Publications (2)

Publication Number Publication Date
JPS59157021A true JPS59157021A (ja) 1984-09-06
JPS6358809B2 JPS6358809B2 (enrdf_load_stackoverflow) 1988-11-17

Family

ID=12333337

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58031515A Granted JPS59157021A (ja) 1983-02-25 1983-02-25 動脈硬化症予防治療剤

Country Status (12)

Country Link
JP (1) JPS59157021A (enrdf_load_stackoverflow)
BE (1) BE899000A (enrdf_load_stackoverflow)
CH (1) CH658389A5 (enrdf_load_stackoverflow)
DE (1) DE3406837A1 (enrdf_load_stackoverflow)
DK (1) DK163712C (enrdf_load_stackoverflow)
FR (1) FR2541577B1 (enrdf_load_stackoverflow)
GB (1) GB2135192B (enrdf_load_stackoverflow)
HK (1) HK45389A (enrdf_load_stackoverflow)
IT (1) IT1178863B (enrdf_load_stackoverflow)
NL (1) NL8400548A (enrdf_load_stackoverflow)
SE (1) SE8400971L (enrdf_load_stackoverflow)
SG (1) SG21189G (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63107926A (ja) * 1986-05-16 1988-05-12 Tanabe Seiyaku Co Ltd 血中脂質改善剤
JPS63107925A (ja) * 1986-05-23 1988-05-12 Tanabe Seiyaku Co Ltd 動脈硬化症予防・治療剤
JPH06172180A (ja) * 1992-12-10 1994-06-21 Tanabe Seiyaku Co Ltd 抗動脈硬化剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
GB1236467A (en) * 1967-10-28 1971-06-23 Tanabe Seiyaku Co Benzothiazepine derivatives

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63107926A (ja) * 1986-05-16 1988-05-12 Tanabe Seiyaku Co Ltd 血中脂質改善剤
JPS63107925A (ja) * 1986-05-23 1988-05-12 Tanabe Seiyaku Co Ltd 動脈硬化症予防・治療剤
JPH06172180A (ja) * 1992-12-10 1994-06-21 Tanabe Seiyaku Co Ltd 抗動脈硬化剤

Also Published As

Publication number Publication date
GB2135192A (en) 1984-08-30
HK45389A (en) 1989-06-16
SE8400971L (sv) 1984-08-26
GB2135192B (en) 1986-10-22
FR2541577A1 (fr) 1984-08-31
SE8400971D0 (sv) 1984-02-22
DE3406837A1 (de) 1984-08-30
JPS6358809B2 (enrdf_load_stackoverflow) 1988-11-17
DK103084A (da) 1984-08-26
FR2541577B1 (fr) 1987-05-22
CH658389A5 (de) 1986-11-14
DE3406837C2 (enrdf_load_stackoverflow) 1990-12-20
DK163712B (da) 1992-03-30
IT8467183A1 (it) 1985-08-24
GB8405060D0 (en) 1984-04-04
DK163712C (da) 1992-08-31
SG21189G (en) 1990-01-26
IT8467183A0 (it) 1984-02-24
IT1178863B (it) 1987-09-16
NL8400548A (nl) 1984-09-17
DK103084D0 (da) 1984-02-24
BE899000A (fr) 1984-06-18

Similar Documents

Publication Publication Date Title
RU2340342C2 (ru) СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ ОСТРЫХ И ХРОНИЧЕСКИХ НАРУШЕНИЙ МОЗГОВОГО КРОВООБРАЩЕНИЯ, В ТОМ ЧИСЛЕ ИНСУЛЬТА, НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО[4,3-b]ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ
AU2004216452A1 (en) Use of the dextrogyral enantiomer of milnacipran for the preparation of a drug
US20080058303A1 (en) Use of melagatran
WO2001066096A2 (en) Compositions for prevention and treatment of dementia
RU2012110592A (ru) Соединения и способ снижения мочевой кислоты
EA003142B1 (ru) Лекарственное средство, обладающее антидепрессивным действием, его применение и способ лечения
JP6850499B2 (ja) 排尿障害を予防又は改善させる医薬組成物、排尿障害関連受容体に関する拮抗剤又はその医薬組成物又は拮抗剤を用いた排尿障害を予防又は改善させる方法
CN104382905A (zh) 羧胺三唑(cai)乳清酸盐在黄斑变性中的用途
US4735968A (en) Method of treating tinnitus with AOAA
JP2004521150A (ja) 尿失禁治療用アリール（またはヘテロアリール）アゾリルカルビノール誘導体
EP0363671A2 (de) Verwendung von ACE-Inhibitoren gegen Neointimabildung nach Gefässverletzung
US5854233A (en) Method of treating liver disease and like indications with vasodilating agents
JP2007508371A (ja) 軟骨再生剤としてアピゲニンを含有する骨関節炎治療組成物
JPS59157021A (ja) 動脈硬化症予防治療剤
JPH0699310B2 (ja) アセトアルデヒド解毒剤
KR100851938B1 (ko) 방광 질환의 치료를 위한 카프-오피에이트 작용제
JPS62167725A (ja) 卒中治療剤
JPH07173051A (ja) 家畜用錠剤
JP4628622B2 (ja) 冠状動脈移植片血管攣縮の治療または予防方法
JP2003201238A (ja) 脳梗塞治療用医薬組成物
JPH0680009B2 (ja) 抗高血圧組み合わせ医薬
JP2616845B2 (ja) システノール酸又はその胆汁酸抱合体を含有する血中コレステロール低下剤
CN116650490B (zh) 化合物mt-1207在降低尿酸方面的应用
JPH03193730A (ja) 治療剤
KR101758949B1 (ko) 활성 성분으로 ｌ-카르니틴 또는 프로피오닐 ｌ-카르니틴을 포함하는, 만성 정맥 기능부전의 예방 또는 치료용 복합 조성물